Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

被引：29

作者：

Davies, Faith E. ^{[1
]}

Pawlyn, Charlotte ^{[2
,3
]}

Usmani, Saad Z. ^{[4
]}

San-Miguel, Jesus F. ^{[5
]}

Einsele, Hermann ^{[6
]}

Boyle, Eileen M. ^{[1
]}

Corre, Jill ^{[7
,8
]}

Auclair, Daniel ^{[9
]}

Cho, Hearn Jay ^{[9
,10
]}

Lonial, Sagar ^{[11
]}

Sonneveld, Pieter ^{[12
]}

Stewart, A. Keith ^{[13
,14
]}

Bergsagel, P. Leif ^{[15
]}

Kaiser, Martin F. ^{[3
,16
]}

Weisel, Katja ^{[17
]}

Keats, Jonathan J. ^{[18
]}

Mikhael, Joseph R. ^{[19
]}

Morgan, Kathryn E. ^{[20
]}

Ghobrial, Irene M. ^{[21
]}

Orlowski, Robert Z. ^{[22
]}

Landgren, C. Ola ^{[23
]}

Gay, Francesca ^{[24
]}

Caers, Joseph ^{[25
]}

Chng, Wee Joo ^{[26
,27
,28
,29
]}

Chari, Ajai ^{[10
]}

Walker, Brian A. ^{[30
]}

Kumar, Shaji K. ^{[31
]}

Costa, Luciano J. ^{[32
]}

Anderson, Kenneth C. ^{[21
]}

Morgan, Gareth J. ^{[1
]}

机构：

[1] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[2] Inst Canc Res, Div Canc Therapeut, London, England

[3] Royal Marsden Hosp, Dept Haematol, London, England

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[5] Clin Univ Navarra, CIBERONC, IDISNA, CIMA, Pamplona, Spain

[6] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[7] Inst Univ Canc, Unite Genom Myelome, Toulouse, France

[8] Inst Natl Sante & Rech Med, Paris, France

[9] Multiple Myeloma Res Fdn, Norwalk, CT USA

[10] Icahn Sch Med Mt Sinai, Multiple Myeloma Ctr Excellence, New York, NY 10029 USA

[11] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[12] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[13] Univ Hlth Network, Toronto, ON, Canada

[14] Princess Margaret Canc Ctr, Toronto, ON, Canada

[15] Mayo Clin, Dept Med, Phoenix, AZ USA

[16] Inst Canc Res, Div Genet & Epidemiol, London, England

[17] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany

[18] Translat Genom Res Inst, Integrated Canc Genom, Phoenix, AZ USA

[19] City Hope Canc Ctr, Translat Genom Res Inst, Phoenix, AZ USA

[20] Myeloma Patients Europe, Brussels, Belgium

[21] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[22] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[23] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Program, Miami, FL USA

[24] Univ Torino, Div Hematol, Turin, Italy

[25] Ctr Hosp Univ CHU Liege, Dept Hematol, Liege, Belgium

[26] Natl Univ Canc Inst, Singapore, Singapore

[27] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore

[28] Natl Univ Singapore, NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore

[29] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore

[30] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol Oncol, Indianapolis, IN USA

[31] Mayo Clin, Dept Hematol, Rochester, MN USA

[32] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA

来源：

BLOOD CANCER DISCOVERY | 2022年 / 3卷 / 07期

关键词：

STEM-CELL TRANSPLANTATION; INTERNATIONAL STAGING SYSTEM; MINIMAL RESIDUAL DISEASE; TERM-FOLLOW-UP; LENALIDOMIDE MAINTENANCE; PLUS BORTEZOMIB; GENE-EXPRESSION; DOUBLE-BLIND; DEXAMETHASONE; THERAPY;

D O I：

10.1158/2643-3230.BCD-21-0205

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The multiple myeloma treatment landscape has changed dramatically. This change, paralleled by an increase in scientific knowledge, has resulted in significant improvement in survival. However, heterogeneity remains in clinical outcomes, with a proportion of patients not benefiting from current approaches and continu-ing to have a poor prognosis. A significant proportion of the variability in outcome can be predicted on the basis of clinical and biochemical parameters and tumor-acquired genetic variants, allowing for risk stratification and a more personalized approach to therapy. This article discusses the principles that can enable the rational and effective development of therapeutic approaches for high-risk multiple myeloma.

引用

页码：273 / 284

页数：12

共 108 条

[21] Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial
Croft, James
Ellis, Sidra
Sherborne, Amy L.
Sharp, Kim
Price, Amy
Jenner, Matthew W.
Drayson, Mark T.
Owen, Roger G.
Chown, Sally
Lindsay, Jindriska
Karunanithi, Kamaraj
Hunter, Hannah
Gregory, Walter M.
Davies, Faith E.
Morgan, Gareth J.
Cook, Gordon
Atanesyan, Lilit
Savola, Suvi
Cairns, David A.
Jackson, Graham
Houlston, Richard S.
Kaiser, Martin F.
[J]. LEUKEMIA, 2021, 35 (07) : 2043 - 2053
[22] A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 Patients Collected By European Myeloma Network within Harmony Big Data Platform
D'Agostino, Mattia
Lahuerta, Juan-Jose
Wester, Ruth
Waage, Anders
Bertsch, Uta
Zamagni, Elena
Mateos, Maria-Victoria
Larocca, Alessandra
Dall'Olio, Daniele
van de Donk, Niels W. C. J.
Cairns, David
Rocchi, Serena
Salwender, Hans
Creixenti, Joan Blade
van der Holt, Bronno
Gastone, Castellani
Ciccone, Giovannino
Capra, Andrea
Durig, Jan
Bringhen, Sara
Zweegman, Sonja
Cavo, Michele
Goldschmidt, Hartmut
Cook, Gordon
Hernandez-Rivas, Jesus Maria
San-Miguel, Jesus F.
Boccadoro, Mario
Sonneveld, Pieter
[J]. BLOOD, 2020, 136
[23] Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma
Da Via, Matteo C.
Dietrich, Oliver
Truger, Marietta
Arampatzi, Panagiota
Duell, Johannes
Heidemeier, Anke
Zhou, Xiang
Danhof, Sophia
Kraus, Sabrina
Chatterjee, Manik
Meggendorfer, Manja
Twardziok, Sven
Goebeler, Maria-Elisabeth
Topp, Max S.
Hudecek, Michael
Prommersberger, Sabrina
Hege, Kristen
Kaiser, Shari
Fuhr, Viktoria
Weinhold, Niels
Rosenwald, Andreas
Erhard, Florian
Haferlach, Claudia
Einsele, Hermann
Kortuem, K. Martin
Saliba, Antoine-Emmanuel
Rasche, Leo
[J]. NATURE MEDICINE, 2021, 27 (04) : 616 - 619
[24] Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
Danziger, Samuel A.
McConnell, Mark
Gockley, Jake
Young, Mary H.
Rosenthal, Adam
Schmitz, Frank
Reiss, David J.
Farmer, Phil
Alapat, Daisy, V
Singh, Amrit
Ashby, Cody
Bauer, Michael
Ren, Yan
Smith, Kelsie
Couto, Suzana S.
van Rhee, Frits
Davies, Faith
Zangari, Maurizio
Petty, Nathan
Orlowski, Robert Z.
Dhodapkar, Madhav, V
Copeland, Wilbert B.
Fox, Brian
Hoering, Antje
Fitch, Alison
Newhall, Katie
Barlogie, Bart
Trotter, Matthew W. B.
Hershberg, Robert M.
Walker, Brian A.
Dervan, Andrew P.
Ratushny, Alexander, V
Morgan, Gareth J.
[J]. PLOS MEDICINE, 2020, 17 (11)
[25] Diamond B, 2021, LANCET HAEMATOL, V8, pE422, DOI 10.1016/S2352-3026(21)00130-7
[26] Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Dimopoulos, Meletios A.
Gay, Francesca
Schjesvold, Fredrik
Beksac, Meral
Hajek, Roman
Weisel, Katja Christina
Goldschmidt, Hartmut
Maisnar, Vladimir
Moreau, Philippe
Min, Chang Ki
Pluta, Agnieszka
Chng, Wee-Joo
Kaiser, Martin
Zweegman, Sonja
Mateos, Maria-Victoria
Spencer, Andrew
Iida, Shinsuke
Morgan, Gareth
Suryanarayan, Kaveri
Teng, Zhaoyang
Skacel, Tomas
Palumbo, Antonio
Dash, Ajeeta B.
Gupta, Neeraj
Labotka, Richard
Rajkumar, S. Vincent
Bar, Daniel
Basso, Alfredo
Fantl, Dorotea
He, Simon
Horvath, Neomi
Lee, Cindy
Rowlings, Phillip
Taylor, Kerry
Cochrane, Tara
Kwok, Fiona
Ramanathan, Sundreswran
Agis, Hermine
Zojer, Niklas
Kentos, Alain
Offner, Fritz
Van Droogenbroeck, Jan
Wu, Ka Lung
Maiolino, Angelo
Martinez, Gracia
Zanella, Karla
Capra, Marcelo
Araujo, Sergio
Gregora, Evzen
Pour, Ludek
[J]. LANCET, 2019, 393 (10168) : 253 - 264
[27] Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Facon, T.
Kumar, S.
Plesner, T.
Orlowski, R. Z.
Moreau, P.
Bahlis, N.
Basu, S.
Nahi, H.
Hulin, C.
Quach, H.
Goldschmidt, H.
O'Dwyer, M.
Perrot, A.
Venner, C. P.
Weisel, K.
Mace, J. R.
Raje, N.
Attal, M.
Tiab, M.
Macro, M.
Frenzel, L.
Leleu, X.
Ahmadi, T.
Chiu, C.
Wang, J.
Van Rampelbergh, R.
Uhlar, C. M.
Kobos, R.
Qi, M.
Usmani, S. Z.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (22) : 2104 - 2115
[28] Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Facon, Thierry
Dimopoulos, Meletios A.
Dispenzieri, Angela
Catalano, John V.
Belch, Andrew
Cavo, Michele
Pinto, Antonello
Weisel, Katja
Ludwig, Heinz
Bahlis, Nizar J.
Banos, Anne
Tiab, Mourad
Delforge, Michel
Cavenagh, Jamie D.
Geraldes, Catarina
Lee, Je-Jung
Chen, Christine
Oriol, Albert
De La Rubia, Javier
White, Darrell
Binder, Daniel
Lu, Jin
Anderson, Kenneth C.
Moreau, Philippe
Attal, Michel
Perrot, Aurore
Arnulf, Bertrand
Qiu, Lugui
Roussel, Murielle
Boyle, Eileen
Manier, Salomon
Mohty, Mohamad
Avet-Loiseau, Herve
Leleu, Xavier
Ervin-Haynes, Annette
Chen, Guang
Houck, Vanessa
Benboubker, Lotfi
Hulin, Cyrille
[J]. BLOOD, 2018, 131 (03) : 301 - 310
[29] Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Fernandez de Larrea, Carlos
Kyle, Robert
Rosinol, Laura
Paiva, Bruno
Engelhardt, Monika
Usmani, Saad
Caers, Jo
Gonsalves, Wilson
Schjesvold, Fredrik
Merlini, Giampaolo
Lentzch, Suzanne
Ocio, Enrique
Garderet, Laurent
Moreau, Philippe
Sonneveld, Pieter
Badros, Ashraf
Gahrton, Gosta
Goldschmidt, Hartmut
Tuchman, Sascha
Einsele, Hermann
Durie, Brian
Wirk, Baldeep
Musto, Pellegrino
Hayden, Patrick
Kaiser, Martin
San Miguel, Jesus
Blade, Joan
Rajkumar, S. Vincent
Victoria Mateos, Maria
[J]. BLOOD CANCER JOURNAL, 2021, 11 (12)
[30] Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
Gambella, Manuela
Omede, Paola
Spada, Stefano
Muccio, Vittorio Emanuele
Gilestro, Milena
Saraci, Elona
Grammatico, Sara
Larocca, Alessandra
Conticello, Concetta
Bernardini, Annalisa
Gamberi, Barbara
Troia, Rossella
Liberati, Anna Marina
Offidani, Massimo
Rocci, Alberto
Palumbo, Antonio
Cavo, Michele
Sonneveld, Pieter
Boccadoro, Mario
Oliva, Stefania
[J]. CANCER, 2019, 125 (05) : 750 - 760

← 1 2 3 4 5 6 7 8 9 10 →